Company news
Neuronetics, Inc. news in 2023
Neuronetics, Inc.'s news releases, calls and decks from 2023, newest first.
Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement Accessory
December 17, 2023
NeuroStar TMS Receives Expanded Regulatory Approval in Japan
December 3, 2023
Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference
November 14, 2023
NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements
November 12, 2023
Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage
November 8, 2023
Neuronetics Reports Third Quarter 2023 Financial and Operating Results
November 6, 2023
Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call
October 23, 2023
Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility
October 2, 2023
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
September 11, 2023
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
August 20, 2023
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
August 13, 2023
Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results
August 7, 2023
Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
July 24, 2023
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
July 18, 2023
NeuroStar Achieves Milestone Regulatory Clearance in South Korea
July 16, 2023
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
July 10, 2023
Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy
June 11, 2023
Neuronetics investing in NeuroStar awareness as drug-free treatment alternative for depression
May 29, 2023
Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
May 25, 2023
Neuronetics to Present at the William Blair 43rd Annual Growth Stock Conference
May 23, 2023
New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction
May 22, 2023
Neuronetics Wins 2023 Bell Seal for Workplace Mental Health
May 14, 2023
Neuronetics to Present at the JMP Securities Life Sciences Conference
May 8, 2023
Neuronetics Reports Record First Quarter 2023 Financial and Operating Results
May 8, 2023
Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR
May 7, 2023
Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer
April 30, 2023
Neuronetics Announces Expanded TMS Access through United HealthCare
April 27, 2023
Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy
April 12, 2023
Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note
April 3, 2023
Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results
March 6, 2023
Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives
March 1, 2023
Neuronetics Expands NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform
February 22, 2023
Neuronetics Announces Elevation of Sara Grubbs to SVP, Chief Revenue Officer
February 15, 2023
Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners
February 9, 2023
Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership
January 18, 2023
Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health
January 16, 2023
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results
January 8, 2023